PFIZER, INC.

PFE

Delayed - 07/01 04:03:09 pm
52.31USD	-0.23%

Turn to zoom

Prev.	52.3100
Open	52.0400
High	52.3700
Low	51.2500
Volume	16 135 661

1d ago	Arbitrator Rules Employer's Two-Dose COVID Vaccine Requirement Not...
1d ago	Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID
2d ago	Pharmaceutical companies still have the upper hand
2d ago	Pfizer Files New Drug Application For COVID-19 Antiviral Pill

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Neutral
Resistance	54,0	59,1	59,5
Spread/Res.	-3,1%	-11%	-12%
Spread/Supp.	14%	14%	26%
Support	45,8	45,8	41,5

Sales 2022	104 B - -
Net income 2022	35 924 M - -
Net cash 2022	12 888 M - -
P/E ratio 2022	8,70x
Yield 2022	3,10%

Capitalization	294 B 294 B -
EV / Sales 2022	2,70x
EV / Sales 2023	3,42x
Nbr of Employees	79 000
Free-Float	59,0%

Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- vaccines (52.4%);
- drugs for the treatment of cancer (15.2%);
- cardiovascular, metabolic and analgesic drugs (11.5%);
- injectable, anti-infectives drugs and active pharmaceutical...

Sector :

Other Pharmaceuticals

Calendar :

2022-07-28 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	23
Last Close Price	52,31 $
Average target price	57,00 $
Spread / Average Target	8,97%